CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 10 enrolled
Drug / intervention
Prednisolone synthetic cortisone and Isoproterenol togetherdrug
Likely dose
Prednisolone synthetic cortisone and Isoproterenol together 0.08 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00624416
NCT00624416Phase 2Completed
CompareCT.gov

A Pilot Study: Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas

Pennington Biomedical Research Center·interventional·Posted Feb 27, 2008·Updated Dec 21, 2015

In Brief

A Phase 2 clinical trial evaluating Prednisolone synthetic cortisone and Isoproterenol together for Lipoma. Completed, enrolled 10 participants across 1 site.

Detailed Summary

The purpose of this study is to test whether injected medications will increase the amount of fat released by a fat cell. We will compare prednisolone (a synthetic cortisone) combined with isoproterenol (a drug given for asthma) versus using isoproterenol alone. We will also test if injections of isoproterenol and prednisolone will shrink the size of lipomas, which are benign fatty tumors.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLipoma
CountriesUnited States
CollaboratorsLipothera

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 27, 2008
Enrollment StartOct 1, 2007
Primary CompletionMar 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 18.3 years ago

Interventions

Prednisolone synthetic cortisone and Isoproterenol togetherdrug

Approximately 0.2 to 0.4cc of isoproterenol-prednisolone solution (0.04 - 0.08 mg isoproterenol and 0.07 - 0.14 mg prednisolone) in one or more sites in the lipoma depending on its size, 5 days a week for 4 weeks.